羟基尿作为放疗增敏剂的临床研究进展

Achievement of Hydroxyurea in Clinical Trials as Radiosensitizer

近年来许多国外研究者将放疗增敏剂羟基尿与另外两个放疗增敏剂５氟尿嘧啶、顺铂联用，试图构成一个最佳组 合，配合放疗治疗晚期实体瘤，获得了良好的结果。

Recently a number of investigators have been striving to combine hydroxyurea, a radiosensitizer, with fluorouracil and cisplatin to form optimum synergy adjuncting to radiotherapy in the treatment of advanced solid tumors .Excellent results were observed.